A Novel Antisense Oligodeoxynucleotide-Doxorubicin Conjugate Against the Multidrug Resistance Gene Mdr1:Inhibition to KB-A-1 Cell and P-glycoprotein Expression

詹晓云,任宇红,张强,卢艳花,魏东芝,刘建文

DOI: https://doi.org/10.3969/j.issn.1009-2501.2004.04.011

2004-01-01

Abstract:Over-expression of P-glycoprotein(P-gp) on the surface of tumor cells that works as a membrane pump enhancing the drug efflux is regarded as a main candidate mechanism of multidrug resistance(MDR). And mdr1 is one of the two main genes that encode P-gp in human cells. In this study, a novel conjugate made of mdr 1-anti-sense oligodeoxynucleotide(ODN) and a potent anticancer drug doxorubicin was constructed. The cytotoxicity of the conjugate as well as the effect of the conjugate on the modulation of P-gp-mediated MDR in KB-A-1 cell lines was studied. The molecular mechanism of its regulation effect was also investigated. METHODS: Multidrug resistant KB-A-1 cell lines were used. MTF was applied to measure the cytotoxicity of the conjugate and doxorubicin to KB-A-1 cells.Effect of the conjugate on intracellular doxorubicin accumulation was determined by HPLC. RT-PCR and Western blot were used to determine the expression of mdr 1 gene and P-glycoprotein in KB-A-1 cells. RESULRTS: The results showed that the conjugate exhibited more cytotoxicity than ODN, and also it could promote the cytotoxicity of doxorubicin to KB-A-1 cells. The IC50 of doxorubicin dropped from 24 to 18 μg·ml-1. The results of RT-PCR and Western blot analysis illuminated that conjugate might down-regulate the P-gp expression. CONCLUSION: All the findings suggest that the conjugate is more potential for efficient reversal of MDR phenomenon than free ODN.The study indicated that such a conjugate should be a new feasible and efficient anti-sense reagent both in lab research and further in clinical therapy.